Stanley Hazen is a Cardiology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave.
Cleveland, OH 441950001
Telephone
800-223-2273Provider last certified this registry record 19 May 2022.
Clinical trials
- Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
Sponsor: The Cleveland Clinic
- GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease
Sponsor: The Cleveland Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.4%Cholesterol absorption inhibitor23.2%Ezetimibe100%Part D≥40 patientsStatin17.5%Rosuvastatin Calcium57%Atorvastatin Calcium43%Part D≥17 patients+ 7 more classes in this area
Musculoskeletal
17.8%Alkaloid17.8%Colchicine100%Part D≥30 patientsHormonal (systemic)
2.9%l-Thyroxine2.9%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
23 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- Gut Microbiota and Cardiometabolic Diseases
Cleveland Clinic Lerner Com-Cwru
FY2026$2,492,487P01HL147823 - Artificial sweeteners and cardiovascular disease
Cleveland Clinic Lerner Com-Cwru
FY2026$780,467R01HL172805 - Gut microbial dietary phenylalanine metabolism and heart failure
Cleveland Clinic Lerner Com-Cwru
FY2026$774,267R01HL167831
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”